These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 9674796)

  • 21. Diagnostic and Prognostic Value of the Combination of Two Measures of Verbal Memory in Mild Cognitive Impairment due to Alzheimer's Disease.
    Sala I; Illán-Gala I; Alcolea D; Sánchez-Saudinós MB; Salgado SA; Morenas-Rodríguez E; Subirana A; Videla L; Clarimón J; Carmona-Iragui M; Ribosa-Nogué R; Blesa R; Fortea J; Lleó A
    J Alzheimers Dis; 2017; 58(3):909-918. PubMed ID: 28527215
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CERAD neuropsychological compound scores are accurate in detecting prodromal alzheimer's disease: a prospective AddNeuroMed study.
    Paajanen T; Hänninen T; Tunnard C; Hallikainen M; Mecocci P; Sobow T; Tsolaki M; Vellas B; Lovestone S; Soininen H
    J Alzheimers Dis; 2014; 39(3):679-90. PubMed ID: 24246420
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cognitive evaluation of patients with glaucoma and its comparison with individuals with Alzheimer's disease.
    Maurano STP; da Silva DJ; Ávila MP; Magacho L
    Int Ophthalmol; 2018 Oct; 38(5):1839-1844. PubMed ID: 28744790
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The CERAD neuropsychological assessment battery total score detects and predicts Alzheimer disease dementia with high diagnostic accuracy.
    Wolfsgruber S; Jessen F; Wiese B; Stein J; Bickel H; Mösch E; Weyerer S; Werle J; Pentzek M; Fuchs A; Köhler M; Bachmann C; Riedel-Heller SG; Scherer M; Maier W; Wagner M;
    Am J Geriatr Psychiatry; 2014 Oct; 22(10):1017-28. PubMed ID: 23759289
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Education, cognitive function, and severity of neuropathology in Alzheimer disease.
    Koepsell TD; Kurland BF; Harel O; Johnson EA; Zhou XH; Kukull WA
    Neurology; 2008 May; 70(19 Pt 2):1732-9. PubMed ID: 18160675
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part I. Clinical and neuropsychological assessment of Alzheimer's disease.
    Morris JC; Heyman A; Mohs RC; Hughes JP; van Belle G; Fillenbaum G; Mellits ED; Clark C
    Neurology; 1989 Sep; 39(9):1159-65. PubMed ID: 2771064
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characterizing Apolipoprotein E ε4 Carriers and Noncarriers With the Clinical Diagnosis of Mild to Moderate Alzheimer Dementia and Minimal β-Amyloid Peptide Plaques.
    Monsell SE; Kukull WA; Roher AE; Maarouf CL; Serrano G; Beach TG; Caselli RJ; Montine TJ; Reiman EM
    JAMA Neurol; 2015 Oct; 72(10):1124-31. PubMed ID: 26302353
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Progression of Alzheimer's Disease Can Be Assessed with a Short Version of the CERAD Neuropsychological Battery: The Kuopio ALSOVA Study.
    Hallikainen I; Martikainen J; Lin PJ; Cohen JT; Lahoz R; Välimäki T; Hongisto K; Väätäinen S; Vanhanen M; Neumann PJ; Hänninen T; Koivisto AM
    Dement Geriatr Cogn Dis Extra; 2014; 4(3):494-508. PubMed ID: 25685140
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cerebral infarction in Alzheimer's disease is associated with severe amyloid angiopathy and hypertension.
    Olichney JM; Hansen LA; Hofstetter CR; Grundman M; Katzman R; Thal LJ
    Arch Neurol; 1995 Jul; 52(7):702-8. PubMed ID: 7619027
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Incidence of cerebrovascular lesions in Alzheimer's disease: a postmortem study.
    Jellinger KA; Attems J
    Acta Neuropathol; 2003 Jan; 105(1):14-7. PubMed ID: 12471455
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A total score for the CERAD neuropsychological battery.
    Chandler MJ; Lacritz LH; Hynan LS; Barnard HD; Allen G; Deschner M; Weiner MF; Cullum CM
    Neurology; 2005 Jul; 65(1):102-6. PubMed ID: 16009893
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lewy body variant of Alzheimer's disease and Alzheimer's disease: a comparative immunohistochemical study.
    Szpak GM; Lewandowska E; Lechowicz W; Bertrand E; Wierzba-Bobrowicz T; Gwiazda E; Pasennik E; Kosno-Kruszewska E; Lipczyńska-Lojkowska W; Bochyńska A; Fiszer U
    Folia Neuropathol; 2001; 39(2):63-71. PubMed ID: 11680637
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CERAD (Consortium to Establish a Registry for Alzheimer's Disease) Neuropsychology Assessment Battery: 35 Years and Counting.
    Fillenbaum GG; Mohs R
    J Alzheimers Dis; 2023; 93(1):1-27. PubMed ID: 36938738
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Incremental value of biomarker combinations to predict progression of mild cognitive impairment to Alzheimer's dementia.
    Frölich L; Peters O; Lewczuk P; Gruber O; Teipel SJ; Gertz HJ; Jahn H; Jessen F; Kurz A; Luckhaus C; Hüll M; Pantel J; Reischies FM; Schröder J; Wagner M; Rienhoff O; Wolf S; Bauer C; Schuchhardt J; Heuser I; Rüther E; Henn F; Maier W; Wiltfang J; Kornhuber J
    Alzheimers Res Ther; 2017 Oct; 9(1):84. PubMed ID: 29017593
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neuropsychological correlates of the P300 in patients with Alzheimer's disease.
    Lee MS; Lee SH; Moon EO; Moon YJ; Kim S; Kim SH; Jung IK
    Prog Neuropsychopharmacol Biol Psychiatry; 2013 Jan; 40():62-9. PubMed ID: 22940475
    [TBL] [Abstract][Full Text] [Related]  

  • 36. "Preclinical" AD revisited: neuropathology of cognitively normal older adults.
    Schmitt FA; Davis DG; Wekstein DR; Smith CD; Ashford JW; Markesbery WR
    Neurology; 2000 Aug; 55(3):370-6. PubMed ID: 10932270
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Glucose levels during life and neuropathologic findings at autopsy among people never treated for diabetes.
    Crane PK; Walker RL; Sonnen J; Gibbons LE; Melrose R; Hassenstab J; Keene CD; Postupna N; Montine TJ; Larson EB
    Neurobiol Aging; 2016 Dec; 48():72-82. PubMed ID: 27644076
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part XI. Clinical milestones in patients with Alzheimer's disease followed over 3 years.
    Galasko D; Edland SD; Morris JC; Clark C; Mohs R; Koss E
    Neurology; 1995 Aug; 45(8):1451-5. PubMed ID: 7644039
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Microglia activation in the brain as inflammatory biomarker of Alzheimer's disease neuropathology and clinical dementia.
    Xiang Z; Haroutunian V; Ho L; Purohit D; Pasinetti GM
    Dis Markers; 2006; 22(1-2):95-102. PubMed ID: 16410654
    [TBL] [Abstract][Full Text] [Related]  

  • 40. REM sleep behavior disorder and dementia: cognitive differences when compared with AD.
    Ferman TJ; Boeve BF; Smith GE; Silber MH; Kokmen E; Petersen RC; Ivnik RJ
    Neurology; 1999 Mar; 52(5):951-7. PubMed ID: 10102411
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.